Search

01/06/2022 Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience
Salvatori, R, Maffei, P, Webb, SM, Brue, T, Loftus, J, Valluri, SR, Gomez, R, Wajnrajch, MP, Fleseriu, M. Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience. Pituitary. 2022; 25(3)DOI:10.1007/s11102-022-01206-2. PMID:35022929. IF:3.800(Q2/5D).
28/05/2022 Data mining analyses for precision medicine in acromegaly: a proof of concept
Gil, J, Marques-Pamies, M, Sampedro, M, Webb, SM, Serra, G, Salinas, I, Blanco, A, Valassi, E, Carrato, C, Pico, A, Garcia-Martinez, A, Martel-Duguech, L, Sardon, T, Simo-Servat, A, Biagetti, B, Villabona, C, Camara, R, Fajardo-Montanana, C, Alvarez-Escola, C, Lamas, C, Alvarez, CV, Bernabeu, I, Marazuela, M, Jorda, M, Puig-Domingo, M. Data mining analyses for precision medicine in acromegaly: a proof of concept. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-12955-2. PMID:35643771. IF:4.600(Q2/4D).
01/02/2022 Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Pardo, JC, de Porras, VR, Gil, J, Font, A, Puig-Domingo, M, Jorda, M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients. 2022; 14(4)DOI:10.3390/nu14040851. PMID:35215499. IF:5.900(Q1/2D).
01/01/2022 Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)
van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).
01/12/2025 Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors
Araujo-Castro, M, Torre, EM, Lozano-Aida, C, Garcia-Centeno, R, Fernandez, LG, Idrobo, C, Achote-Rea, E, Echarri, AI, Rodriguez-Argullo, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Aulinas, A, Roca, QA, Aviles, MD, Mezquita, EL, Fernandez-Argueeso, M, Molero, IG, Ruz-Caracuel, I, Aldecoa, I, Garcia, J, Martinez-Saez, E, Hanzu, F, Marazuela, M, Puig-Domingo, M, Biagetti, B. Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf252. PMID:40277238. IF:5.100(Q1/2D).
01/12/2025 Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity
Aulinas, A, Galbiati, F, Wronski, ML, Carter, CS, Nazarloo, S, Holman, K, Golden, ER, Muhammed, M, Hadaway, N, Asanza, E, Smith, SE, Plessow, F, Lawson, EA. Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf237. PMID:40314146. IF:5.100(Q1/2D).
01/12/2025 Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study
Biagetti, B, Cardona-Arias, A, Torre, EM, Aulinas, A, Ruz-Caracuel, I, Centeno, RG, Gonzalez, L, Echarri, AI, Rodriguez, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Lozano-Aida, C, Roca, QA, Aviles, MD, Mezquita, EL, Argueso, MF, Molero, IG, Alberoa, I, Idrobo, C, Achote, E, Martinez-Saez, E, Marazuela, M, Puig-Domingo, M, Hanzu, F, Araujo-Castro, M. Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2025; 48(12)DOI:10.1007/s40618-025-02674-6. PMID:40779234. IF:3.500(Q2/4D).
01/11/2025 Oxytocin in hypopituitarism: What do we know?
Aulinas, A, Lawson, EA. Oxytocin in hypopituitarism: What do we know?. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:. PMID:41173566. IF:1.800(Q3/8D).